Nisarg Biosciences Profile
Key Indicators
- Authorised Capital ₹ 2.60 Cr
as on 10-12-2024
- Paid Up Capital ₹ 2.60 Cr
as on 10-12-2024
- Company Age 20 Year, 5 Months
- Last Filing with ROC 31 Mar 2023
- Satisfied Charges ₹ 10.90 Cr
as on 10-12-2024
- Revenue -82.20%
(FY 2022)
- Profit 9.88%
(FY 2022)
- Ebitda 225.87%
(FY 2022)
- Net Worth 6.19%
(FY 2022)
- Total Assets 75.25%
(FY 2022)
About Nisarg Biosciences
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 2.60 Cr and a paid-up capital of Rs 2.60 Cr.
The company has closed loans amounting to ₹10.90 Cr, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
Ashwini Agraharam and Vijaykumar Varalwar serve as directors at the Company.
- CIN/LLPIN
U24233TG2004PTC043541
- Company No.
043541
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
25 Jun 2004
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Company Details
- Location
Hyderabad, Telangana, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Nisarg Biosciences Private Limited offer?
Nisarg Biosciences Private Limited offers a wide range of products and services, including Ayurvedic Powder and Medicinal Herbs, Herbal Powder, Ayurvedic & Herbal Extracts, Herbal Extracts, Plant Extracts, Ayurvedic,Herbal Products & Medicine, Herbal Capsules, Spices Extracts, Essential & Aromatic Oils, Carrier Oil.
Who are the key members and board of directors at Nisarg Biosciences?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Ashwini Agraharam  | Managing Director | 25-Jun-2004 | Current |
Board Members(1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Vijaykumar Varalwar | Director | 25-Jun-2004 | Current |
Financial Performance and Corporate Structure Insights of Nisarg Biosciences.
Nisarg Biosciences Private Limited, for the financial year ended 2022, experienced significant reduction in revenue, with a 82.2% decrease. The company also saw a slight improvement in profitability, with a 9.88% increase in profit. The company's net worth moved up by a moderate rise of 6.19%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Nisarg Biosciences?
In 2022, Nisarg Biosciences had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 14 Oct 2020 | ₹2.50 Cr | Satisfied |
State Bank Of Hyderabad Creation Date: 17 Nov 2014 | ₹2.40 Cr | Satisfied |
State Bank Of Hyderabad Creation Date: 21 Jul 2004 | ₹6.00 Cr | Satisfied |
How Many Employees Work at Nisarg Biosciences?
Nisarg Biosciences has a workforce of 0 employees as of Apr 08, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Nisarg Biosciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Nisarg Biosciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
